Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias

Eric E Brown, Sanjeev Kumar, Tarek K Rajji, Bruce G Pollock, Benoit H Mulsant, Eric E Brown, Sanjeev Kumar, Tarek K Rajji, Bruce G Pollock, Benoit H Mulsant

Abstract

The COVID-19 pandemic is causing global morbidity and mortality, straining health systems, and disrupting society, putting individuals with Alzheimer's disease and related dementias (ADRD) at risk of significant harm. In this Special Article, we examine the current and expected impact of the pandemic on individuals with ADRD. We discuss and propose mitigation strategies for: the risk of COVID-19 infection and its associated morbidity and mortality for individuals with ADRD; the impact of COVID-19 on the diagnosis and clinical management of ADRD; consequences of societal responses to COVID-19 in different ADRD care settings; the effect of COVID-19 on caregivers and physicians of individuals with ADRD; mental hygiene, trauma, and stigma in the time of COVID-19; and the potential impact of COVID-19 on ADRD research. Amid considerable uncertainty, we may be able to prevent or reduce the harm of the COVID-19 pandemic and its consequences for individuals with ADRD and their caregivers.

Keywords: Alzheimer's disease and related disorders; COVID-19 pandemic; caregivers; clinical care; clinical research; coronavirus.

Copyright © 2020. Published by Elsevier Inc.

References

    1. World Health Organization: Coronavirus disease 2019 (COVID-19) Situation Report – 51 March 11, 2020. Available at:. Accessed March 31, 2020.
    1. World Health Organization: Coronavirus disease 2019 (COVID-19) Situation Report – 25 February 14, 2020. Available at:. Accessed March 31, 2020.
    1. Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323:2513.
    1. Wu JT, Leung K, Bushman M. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan. China Nat Med. 2020;26:506–510.
    1. Bauer K, Schwarzkopf L, Graessel E. A claims data-based comparison of comorbidity in individuals with and without dementia. BMC Geriatr. 2014;14:1–13.
    1. Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
    1. Guan W, Ni Z, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020
    1. Foley NC, Affoo RH, Martin RE. A systematic review and meta-analysis examining pneumonia-associated mortality in dementia. Dement Geriatr Cogn Disord. 2015;39:52–67.
    1. Ranney ML, Griffeth V, Jha AK. Critical supply shortages — the need for ventilators and personal protective equipment during the Covid-19 pandemic. N Engl J Med. 2020
    1. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020
    1. Davies SJ, Burhan AM, Kim D. Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia. J Psychopharmacol (Oxf) 2018;32:509–523.
    1. Zheng Y-Y, Ma Y-T, Zhang J-Y. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–260.
    1. Iverson DJ, Gronseth GS, Reger MA. Practice parameter update: evaluation and management of driving risk in dementia: report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2010;74:1316–1324.
    1. McMichael TM, Currie DW, Clark S. Epidemiology of Covid-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020 March.
    1. Toot S, Devine M, Akporobaro A. Causes of hospital admission for people with dementia: a systematic review and meta-analysis. J Am Med Dir Assoc. 2013;14:463–470.
    1. Tjia J, Field TS, Mazor KM. Dementia and risk of adverse warfarin-related events in the nursing home setting. Am J Geriatr Pharmacother. 2012;10:323–330.
    1. Kim MJ: ‘It was a medical disaster’: the psychiatric ward that saw 100 patients diagnosed with new coronavirus. The Independent. Available at: . Published March 1, 2020. Accessed April 1, 2020.
    1. Yu R, Topiwala A, Jacoby R. Aggressive behaviors in Alzheimer disease and mild cognitive impairment: systematic review and meta-analysis. Am J Geriatr Psychiatry. 2019;27:290–300.
    1. Tasker JP, Burke A. CBC News; 2020. Canada Turning to Makeshift Hospitals to House Patients as COVID-19 Pandemic Stretches Capacity. Available at: Accessed March 29, 2020.
    1. Wolff JL, Feder J, Schulz R. Supporting family caregivers of older Americans. N Engl J Med. 2016;375:2513–2515.
    1. Christakis NA. Mortality after the hospitalization of a spouse. N Engl J Med. 2006;354:719–730.
    1. Kim M, The right to grieve, JAMA 2019, 321:1569–1570.
    1. Kozloff N, Mulsant BH, Stergiopoulos V. The COVID-19 global pandemic: implications for people with schizophrenia and related disorders. Schizophr Bull. 2020 In press.
    1. Mak IWC, Chu CM, Pan PC. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31:318–326.
    1. Richards KC, Beck C, O'Sullivan PS. Effect of individualized social activity on sleep in nursing home residents with dementia. J Am Geriatr Soc. 2005;53:1510–1517.
    1. Ford AH. Preventing delirium in dementia: managing risk factors. Maturitas. 2016;92:35–40.
    1. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7:323–331.
    1. Tsolaki M, Papaliagkas V, Kounti F. Severely stressful events and dementia: a study of an elderly Greek demented population. Psychiatry Res. 2010;176:51–54.
    1. Alphs L, Brashear HR, Chappell P. Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia. Alzheimers Dement Transl Res Clin Interv. 2016;2:48–59.
    1. Herrmann LK, Welter E, Leverenz J. A systematic review of dementia-related stigma research: can we move the stigma dial? Am J Geriatr Psychiatry. 2018;26:316–331.
    1. CDC: Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. February 11, 2020. Available at:. Accessed March 29, 2020.
    1. Emanuel EJ, Persad G, Upshur R. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020 March.
    1. Nicol GE, Piccirillo JF, Mulsant BH. Action at a distance: geriatric research during a pandemic. J Am Geriatr Soc. 2020 March.
    1. McDermott MM, Newman AB. Preserving clinical trial integrity during the coronavirus pandemic. JAMA. 2020 March.
    1. Cummings J, Lee G, Ritter A. Alzheimer's disease drug development pipeline: 2019. Alzheimers Dement Transl Res Clin Interv. 2019;5:272–293.
    1. Carlson RV, Boyd KM, Webb DJ. The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol. 2004;57:695–713.
    1. U.S. Food and Drug Administration; 2020. Research C for DE and: FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. March 28. Available at: Accessed March 30, 2020.
    1. Kourtis LC, Regele OB, Wright JM. Digital biomarkers for Alzheimer's disease: the mobile/wearable devices opportunity. Npj Digit Med. 2019;9:1–6.
    1. Husebo BS, Heintz HL, Berge LI. Sensing technology to monitor behavioral and psychological symptoms and to assess treatment response in people with dementia. A Systematic Review Front Pharmacol. 2020;10:1699.
    1. Gough N, Brkan L, Subramaniam P. Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: a systematic review. PloS One. 2020;15
    1. Castanho TC, Amorim L, Zihl J. Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments. Front Aging Neurosci. 2014;6:16.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren